Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis

This study has been terminated.

( Inadequate enrollment )

Study NCT00047827 Information provided by Astellas Pharma Inc

First Received: October 18, 2002 Last Updated: September 29, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Aspergillosis

More general conditions related to this trial

Mycoses

Interventions listed in this trial

Additional drug interventions recognized in this trial

Abelcet
Amphotericin B

More general drug interventions related to this trial

Sponsors listed in this trial

Astellas Pharma Inc